Skip to main content

Closed

ARGX: argenx SE Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+78.6% / yr

Operating margin28.8%

ROIC17.4%

Financially safe

Strong

Debt / equity0.01×

Interest coverage393.8×

Current ratio5.12×

Valuation

Unrated

P/E ratio31.1×

argenx SE

ARGXNASDAQ Global Select·USD·Closed

argenx SE

ARGXNASDAQ·USD·Closed

$853.82

−2.15%

$853.82

−$18.76 (2.15%)

52W Range

69thpctl

Volume

0.85×avg

Mkt Cap

53.10BUSD

P/E

31.1TTM

Div Yield

–ann

52W Range

69thpctl

Volume

0.85×avg

Market Cap

53.10BUSD

P/E Ratio

31.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings